Evaluation of cardiac masses by real-time perfusion imaging echocardiography

Abstract

BackgroundDiagnosis of cardiac masses is still challenging by echocardiography and distinguishing tumors from thrombi has important therapeutical implications. We sought to determine the diagnostic value of real-time perfusion echocardiography (RTPE) for cardiac masses characterization.MethodsWe prospectively studied 86 patients, 23 with malignant tumors (MT), 26 with benign tumors (BT), 33 with thrombi and 6 with pseudotumors who underwent RTPE. Mass perfusion was analyzed qualitatively and blood flow volume (A), blood flow velocity (β), and microvascular blood flow (A x β) were determined by quantitative RTPE.ResultsLogistic regression models showed that the probability of having a tumor increased by 15.8 times with a peripheral qualitative perfusion pattern, and 34.5 times with a central perfusion pattern, in comparison with the absence of perfusion. Using quantitative RTPE analysis, thrombi group had parameters of blood flow lower than tumor group. A values for thrombi, MT, and BT were 0.1 dB (0.01-0.22), 2.78 dB (1–7) and 2.58 dB (1.44-5), respectively; p < 0.05, while A x β values were 0.0 dB/s−1 (0.01–0.14), 2.00 dB/s−1 (1–6), and 1.18 dB/s−1 (0.52–3), respectively; p < 0.05. At peak dipyridamole stress, MT had greater microvascular blood volume than BT [A = 4.18 dB (2.14-7.93) versus A = 2.04 dB (1.09-3.55); p < 0.05], but no difference in blood flow [Axβ = 2.46 dB/s−1 (1.42–4.59) versus Axβ = 1.55 dB/s [1] (0.51-4.08); p = NS]. An A value >3.28 dB at peak dipyridamole stress predicted MT (AUC = 0.75) and conferred 5.8-times higher chance of being MT rather than BT.ConclusionRTPE demonstrated that cardiac tumors have greater microvascular blood volume and regional blood flow when compared with thrombi. Dipyridamole stress was useful in differentiating MT from BT.

Clinical diagnostic value of contrast‐enhanced ultrasonography in the diagnosis of cardiac masses: A pilot study

“…Nevertheless, the great limitation of TTE resides in its inability to distinguish between thrombi and benign or malignant tumors. 5 The diagnostic accuracy of TTE depends on the experience of the sonographer and the image quality. This study found that CEUS provides more information to improve the effectiveness of ultrasound diagnostics.…”

A giant, well‐differentiated papillary mesothelioma of the left atrioventricular groove: Case report and brief review of the literature

“…It can provide important information about a mass, including its size, location, boundaries, and blood flow. Contrast echocardiography also helps to differentiate cardiac masses . Computed tomography or magnetic resonance imaging may help in further characterization.…”

“…Contrast echocardiography also helps to differentiate cardiac masses. 7 Computed tomography or magnetic resonance imaging may help in further characterization.…”

Unknown left atrial appendage mass! real-time three-dimensional transesophageal echocardiography helps in identification

“…Real-time perfusion contrast echocardiography can evaluate the vascular pattern of the mass, where the pectinate muscle and tumor show vascularity but thrombi are either avascular or have very low vascularity but this technique has low sensitivity. [ 3 ] The presence of a septic vegetation at the mouth of LAA had been reported that gave an exact picture of floating mass. [ 4 ] LAA is difficult to image by echo from the transthoracic approach, and the TEE has a greater sensitivity and high-negative predictive value for detecting mass in LAA specially thrombus.…”